Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Schulz

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Cell Reports|October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccinationPrerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Cell Host & Microbe|May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodiesPrerna Arora, Lu Zhang, Nadine Krüger, et al.
ACS Synthetic Biology|November 11, 2021
<i>Escherichia coli</i> Data-Driven Strain Design Using Aggregated Adaptive Laboratory Evolution Mutational DataPatrick V Phaneuf, Daniel C Zielinski, James T Yurkovich, et al.
Cell|January 13, 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemicMarkus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Nature Communications|April 29, 2023
A sensitive high repetition rate arrival time monitor for X-ray free electron lasersMichael Diez, Henning Kirchberg, Andreas Galler, et al.
World Journal of Gastroenterology|August 26, 2017
Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutationPhilipp Ellinger, Jan Stindt, Carola Dröge, et al.
BJUI Compass|April 20, 2026
Primary extragonadal germ cell tumours: Real-world data from a high-volume centreMarc Kidess, Marcus Hentrich, Franz Aschl, et al.
Cell Reports|July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccinationMarkus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|June 6, 2017
Probing Transient Valence Orbital Changes with Picosecond Valence-to-Core X-ray Emission SpectroscopyAnne Marie March, Tadesse A Assefa, Christina Boemer, et al.
Cell|April 1, 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesMarkus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Cell Reports|October 6, 2021
B.1.617.2 enters and fuses lung cells with increased efficiency and evades antibodies induced by infection and vaccinationPrerna Arora, Anzhalika Sidarovich, Nadine Krüger, et al.
Cell Host & Microbe|May 19, 2022
SARS-CoV-2 Omicron sublineages show comparable cell entry but differential neutralization by therapeutic antibodiesPrerna Arora, Lu Zhang, Nadine Krüger, et al.
ACS Synthetic Biology|November 11, 2021
<i>Escherichia coli</i> Data-Driven Strain Design Using Aggregated Adaptive Laboratory Evolution Mutational DataPatrick V Phaneuf, Daniel C Zielinski, James T Yurkovich, et al.
Cell|January 13, 2022
The Omicron variant is highly resistant against antibody-mediated neutralization: Implications for control of the COVID-19 pandemicMarkus Hoffmann, Nadine Krüger, Sebastian Schulz, et al.
Nature Communications|April 29, 2023
A sensitive high repetition rate arrival time monitor for X-ray free electron lasersMichael Diez, Henning Kirchberg, Andreas Galler, et al.
World Journal of Gastroenterology|August 26, 2017
Partial external biliary diversion in bile salt export pump deficiency: Association between outcome and mutationPhilipp Ellinger, Jan Stindt, Carola Dröge, et al.
BJUI Compass|April 20, 2026
Primary extragonadal germ cell tumours: Real-world data from a high-volume centreMarc Kidess, Marcus Hentrich, Franz Aschl, et al.
Cell Reports|July 16, 2021
SARS-CoV-2 variant B.1.617 is resistant to bamlanivimab and evades antibodies induced by infection and vaccinationMarkus Hoffmann, Heike Hofmann-Winkler, Nadine Krüger, et al.
The Journal of Physical Chemistry. C, Nanomaterials and Interfaces|June 6, 2017
Probing Transient Valence Orbital Changes with Picosecond Valence-to-Core X-ray Emission SpectroscopyAnne Marie March, Tadesse A Assefa, Christina Boemer, et al.
Cell|April 1, 2021
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodiesMarkus Hoffmann, Prerna Arora, Rüdiger Groß, et al.
Pageof 11